Global and United States Inflammatory Bowel Disease Therapeutics Market Report & Forecast 2022-2028
Table of Contents1 Study Coverage
1.1 Inflammatory Bowel Disease Therapeutics Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Inflammatory Bowel Disease Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Inflammatory Bowel Disease Therapeutics Market Size for the Year 2017-2028
1.3 Inflammatory Bowel Disease Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Inflammatory Bowel Disease Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Inflammatory Bowel Disease Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Inflammatory Bowel Disease Therapeutics Market Dynamics
1.4.1 Inflammatory Bowel Disease Therapeutics Industry Trends
1.4.2 Inflammatory Bowel Disease Therapeutics Market Drivers
1.4.3 Inflammatory Bowel Disease Therapeutics Market Challenges
1.4.4 Inflammatory Bowel Disease Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Inflammatory Bowel Disease Therapeutics by Type
2.1 Inflammatory Bowel Disease Therapeutics Market Segment by Type
2.1.1 Anti-inflammatory Biologics
2.1.2 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
2.1.3 Corticosteroids
2.2 Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2017-2028)
2.4 United States Inflammatory Bowel Disease Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Inflammatory Bowel Disease Therapeutics Market Size by Type (2017-2028)
3 Inflammatory Bowel Disease Therapeutics by Application
3.1 Inflammatory Bowel Disease Therapeutics Market Segment by Application
3.1.1 Hospital Use
3.1.2 Home Use
3.2 Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2017-2028)
3.4 United States Inflammatory Bowel Disease Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Inflammatory Bowel Disease Therapeutics Market Size by Application (2017-2028)
4 Global Inflammatory Bowel Disease Therapeutics Competitor Landscape by Company
4.1 Global Inflammatory Bowel Disease Therapeutics Market Size by Company
4.1.1 Top Global Inflammatory Bowel Disease Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue by Player (2017-2022)
4.2 Global Inflammatory Bowel Disease Therapeutics Concentration Ratio (CR)
4.2.1 Inflammatory Bowel Disease Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Inflammatory Bowel Disease Therapeutics in 2021
4.2.3 Global Inflammatory Bowel Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Inflammatory Bowel Disease Therapeutics Headquarters, Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Inflammatory Bowel Disease Therapeutics Headquarters and Area Served
4.3.2 Global Inflammatory Bowel Disease Therapeutics Companies Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Inflammatory Bowel Disease Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Inflammatory Bowel Disease Therapeutics Market Size by Company
4.5.1 Top Inflammatory Bowel Disease Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Inflammatory Bowel Disease Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Inflammatory Bowel Disease Therapeutics Market Size by Region
5.1 Global Inflammatory Bowel Disease Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Inflammatory Bowel Disease Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Inflammatory Bowel Disease Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Inflammatory Bowel Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Inflammatory Bowel Disease Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Inflammatory Bowel Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Inflammatory Bowel Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Inflammatory Bowel Disease Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Inflammatory Bowel Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbvie
7.1.1 Abbvie Company Details
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Introduction
7.1.4 Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
7.1.5 Abbvie Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Details
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Introduction
7.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
7.2.5 Johnson & Johnson Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Details
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Introduction
7.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
7.3.5 GlaxoSmithKline Recent Development
7.4 Merck
7.4.1 Merck Company Details
7.4.2 Merck Business Overview
7.4.3 Merck Inflammatory Bowel Disease Therapeutics Introduction
7.4.4 Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
7.4.5 Merck Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Inflammatory Bowel Disease Therapeutics Introduction
7.5.4 Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
7.5.5 Novartis Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of TablesTable 1. Inflammatory Bowel Disease Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Inflammatory Bowel Disease Therapeutics Market Trends
Table 3. Inflammatory Bowel Disease Therapeutics Market Drivers
Table 4. Inflammatory Bowel Disease Therapeutics Market Challenges
Table 5. Inflammatory Bowel Disease Therapeutics Market Restraints
Table 6. Global Inflammatory Bowel Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Inflammatory Bowel Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Inflammatory Bowel Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Inflammatory Bowel Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Inflammatory Bowel Disease Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Inflammatory Bowel Disease Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Inflammatory Bowel Disease Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Inflammatory Bowel Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inflammatory Bowel Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2021)
Table 15. Top Players of Inflammatory Bowel Disease Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Inflammatory Bowel Disease Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Inflammatory Bowel Disease Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Inflammatory Bowel Disease Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Inflammatory Bowel Disease Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Inflammatory Bowel Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Inflammatory Bowel Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Inflammatory Bowel Disease Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Inflammatory Bowel Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Inflammatory Bowel Disease Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Inflammatory Bowel Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Inflammatory Bowel Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Inflammatory Bowel Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Abbvie Company Details
Table 31. Abbvie Business Overview
Table 32. Abbvie Inflammatory Bowel Disease Therapeutics Product
Table 33. Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Abbvie Recent Development
Table 35. Johnson & Johnson Company Details
Table 36. Johnson & Johnson Business Overview
Table 37. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product
Table 38. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 39. Johnson & Johnson Recent Development
Table 40. GlaxoSmithKline Company Details
Table 41. GlaxoSmithKline Business Overview
Table 42. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product
Table 43. GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 44. GlaxoSmithKline Recent Development
Table 45. Merck Company Details
Table 46. Merck Business Overview
Table 47. Merck Inflammatory Bowel Disease Therapeutics Product
Table 48. Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Merck Recent Development
Table 50. Novartis Company Details
Table 51. Novartis Business Overview
Table 52. Novartis Inflammatory Bowel Disease Therapeutics Product
Table 53. Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
List of FiguresFigure 1. Inflammatory Bowel Disease Therapeutics Product Picture
Figure 2. Global Inflammatory Bowel Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Inflammatory Bowel Disease Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Inflammatory Bowel Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Inflammatory Bowel Disease Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Inflammatory Bowel Disease Therapeutics Market Share in Global 2017-2028
Figure 7. Inflammatory Bowel Disease Therapeutics Report Years Considered
Figure 8. Product Picture of Anti-inflammatory Biologics
Figure 9. Product Picture of Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Figure 10. Product Picture of Corticosteroids
Figure 11. Global Inflammatory Bowel Disease Therapeutics Market Share by Type in 2022 & 2028
Figure 12. Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Inflammatory Bowel Disease Therapeutics Market Share by Type (2017-2028)
Figure 14. United States Inflammatory Bowel Disease Therapeutics Market Share by Type in 2022 & 2028
Figure 15. United States Inflammatory Bowel Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Inflammatory Bowel Disease Therapeutics Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospital Use
Figure 18. Product Picture of Home Use
Figure 19. Global Inflammatory Bowel Disease Therapeutics Market Share by Application in 2022 & 2028
Figure 20. Global Inflammatory Bowel Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Inflammatory Bowel Disease Therapeutics Market Share by Application (2017-2028)
Figure 22. United States Inflammatory Bowel Disease Therapeutics Market Share by Application in 2022 & 2028
Figure 23. United States Inflammatory Bowel Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Inflammatory Bowel Disease Therapeutics Market Share by Application (2017-2028)
Figure 25. North America Inflammatory Bowel Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Inflammatory Bowel Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Inflammatory Bowel Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Inflammatory Bowel Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Abbvie Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
Figure 56. Merck Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
Figure 57. Novartis Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed